Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Valeant gets $3.2bn through sale of debt

Executive Summary

Valeant Pharmaceuticals International Inc. has sold $3.2bn in notes to VPII Escrow Corp. The company issued $1.6bn of its 6.75% senior unsecured notes due 2018 and $1.625bn of its 7.5% senior unsecured notes due 2021. Valeant will use the proceeds, along with the $2bn it netted via a concurrent FOPO, to help finance its $8.7bn acquisition of Bausch & Lomb Inc.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
    • OTC, Consumer
Deal Status
  • Final
Deal Type
  • Financing
    • Nonconvertible Debt
    • Private Placement

Related Companies